Pharmacists in Selma, CA Accepting Medicare

25 Pharmacists found. Showing 21 - 25

Mr. Gareth Huw Lloyd, MPHARM Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2640 Floral Ave, Selma, CA 93662 Phone: 559-930-1052

Hai Thanh To, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3400 Floral Ave, Selma, CA 93662 Phone: 559-891-1960

Teklebrhan Brhane Teklehaimanot Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2640 Floral Ave, Selma, CA 93662 Phone: 559-896-7105

Woo Hyun Choi, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2640 Floral Ave, Selma, CA 93662 Phone: 559-896-7105

Mrs. Kesheni Vallabh Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2640 Floral Ave, Selma, CA 93662 Phone: 559-896-7105

News Archive

Heart powered pacemakers and defibrillators

Surplus energy generated by the heart may one day help power pacemakers and defibrillators implanted in cardiac patients, according to research presented at the American Heart Association's Scientific Sessions 2008.

Experimental drug that targets genetic makeup of tumor shows early signs of efficacy against medulloblastomas

Researchers from St. Jude Children's Research Hospital and the Pediatric Brain Tumor Consortium (PBTC) presented at the American Society of Clinical Oncology the findings of a pediatric brain tumor study using an experimental drug that targets the underlying genetic makeup of the tumor. The research focused on a new way to attack the tumors by blocking the Hedgehog pathway that is linked to approximately 20 percent of medulloblastomas.

Scientists investigate how a painful event is processed in the brain

Pain is a negative feeling that we want to get rid of as soon as possible. In order to protect our bodies, we react for example by withdrawing the hand. This action is usually understood as the consequence of the perception of pain.

Echo Therapeutics to raise $3 million from institutional investors

Echo Therapeutics, Inc., a company developing its needle-free Symphony(TM) tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude(TM) SkinPrep System for transdermal drug delivery, announced today that it has entered into definitive agreements with accredited and institutional investors to raise approximately $3 million through the sale of approximately 2.37 million shares of common stock at $1.25 per share through a private placement transaction.

Human error: The most common cause of infant asphyxiation at birth

Findings from a 15-year study published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, indicate that human error is the most common cause of infant asphyxiation at birth. Inadequate fetal monitoring, lack of clinical skills, and failure to obtain senior medical staff assistance are most often cited in Norwegian compensation claims following birth asphyxia.

Read more Medical News

› Verified 9 days ago

• 1
• 2(current)